11 Apr 2023
07:01 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV:Oproeping tot de Gewone Algemene Aandeelhoudersvergadering
|
20101025 Health Services |
Corporate life |
11 Apr 2023
07:01 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Invitation to the Annual Shareholders’ Meeting
|
20101025 Health Services |
Corporate life |
11 Apr 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual Report
|
20101025 Health Services |
Corporate life |
11 Apr 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt publicatie 2022 jaarverslag aan
|
20101025 Health Services |
Corporate life |
04 Apr 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platform
|
20101025 Health Services |
Commercial operations |
04 Apr 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis en APIS Assay Technologies tekenen samenwerkingsovereenkomst voor de ontwikkeling en commercialisering van een subtyperingstest voor borstkanker op het Idylla™ platform
|
20101025 Health Services |
Commercial operations |
31 Mar 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Other subject |
31 Mar 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Other subject |
29 Mar 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023
|
20101025 Health Services |
Other subject |
29 Mar 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis zal jaarverslag 2022 publiceren op 11 april 2023
|
20101025 Health Services |
Other subject |
03 Mar 2023
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notification
|
20101025 Health Services |
Other subject |
03 Mar 2023
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
|
20101025 Health Services |
Other subject |
02 Mar 2023
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis maakt de goedkeuring bekend van de 510(k) door de US FDA van de Idylla™ MSI Test
|
20101025 Health Services |
Other subject |
02 Mar 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test
|
20101025 Health Services |
Other subject |
28 Feb 2023
17:55 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Other subject |
28 Feb 2023
17:55 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Other subject |
24 Feb 2023
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis Creëert Nieuw Inschrijvingsrechtenplan en Vernietigt Uitstaande Pool onder Bestaande Inschrijvingsrechtenplannen
|
20101025 Health Services |
Other subject |
24 Feb 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Creates New Share Option Plan and Cancels Outstanding Pool under Existing Share Option Plans
|
20101025 Health Services |
Other subject |
23 Feb 2023
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis maakt resultaten 2022 en vooruitzichten 2023 bekend
|
20101025 Health Services |
Other subject |
23 Feb 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis announces 2022 results and 2023 outlook
|
20101025 Health Services |
Other subject |
22 Feb 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis announces change in Board composition
|
20101025 Health Services |
Other subject |
22 Feb 2023
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt wijziging in Raad van Bestuur aan
|
20101025 Health Services |
Other subject |
16 Feb 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Announces 2022 Full Year Results on 23 February 2023
|
20101025 Health Services |
Other subject |
16 Feb 2023
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt 2022 jaarresultaten aan op 23 februari 2023
|
20101025 Health Services |
Other subject |
09 Feb 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Announces the Launch of the First Assay Developed With the New Idylla™ Flex Technology
|
20101025 Health Services |
Other subject |
09 Feb 2023
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: BIOCARTIS MAAKT DE LANCERING BEKEND VAN DE EERSTE ASSAY ONTWIKKELD MET DE NIEUWE IDYLLA™ FLEX-TECHNOLOGIE
|
20101025 Health Services |
Other subject |
31 Jan 2023
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Other subject |
31 Jan 2023
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Other subject |
17 Jan 2023
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: BIOCARTIS BEHAALT BELANGRIJKSTE 2022 DOELSTELLINGEN
|
20101025 Health Services |
Commercial results |
17 Jan 2023
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY OBJECTIVES
|
20101025 Health Services |
Commercial results |
16 Jan 2023
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Voltooiing van alomvattende herkapitalisatie transacties
|
20101025 Health Services |
Corporate life |
16 Jan 2023
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Completion of Comprehensive Recapitalization Transactions
|
20101025 Health Services |
Corporate life |
04 Jan 2023
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgevingen
|
20101025 Health Services |
Other financial transaction |
04 Jan 2023
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notifications
|
20101025 Health Services |
Other financial transaction |
22 Dec 2022
17:45 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of a transparency notification
|
20101025 Health Services |
Other financial transaction |
22 Dec 2022
17:45 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van een transparantiekennisgeving
|
20101025 Health Services |
Other financial transaction |
22 Dec 2022
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Change in Capital |
22 Dec 2022
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Change in Capital |
16 Dec 2022
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Completion of Mandatory Conversion
|
20101025 Health Services |
Other financial transaction |
16 Dec 2022
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Voltooiing van verplichte conversie
|
20101025 Health Services |
Other financial transaction |
09 Dec 2022
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notifications
|
20101025 Health Services |
Change in Capital |
09 Dec 2022
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgevingen
|
20101025 Health Services |
Change in Capital |
05 Dec 2022
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Mandatory Conversion Bondholder Notification
|
20101025 Health Services |
Other financial transaction |
05 Dec 2022
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Kennisgeving van Verplichte Conversie aan de Obligatiehouders
|
20101025 Health Services |
Other financial transaction |
02 Dec 2022
17:45 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van een transparantiekennisgeving
|
20101025 Health Services |
Other financial transaction |
02 Dec 2022
17:45 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of a transparency notification
|
20101025 Health Services |
Other financial transaction |
02 Dec 2022
17:40 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Change in Capital |
02 Dec 2022
17:40 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Change in Capital |
30 Nov 2022
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Change in Capital |
30 Nov 2022
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Change in Capital |